Product image of Certican (Everolimus) supplied by GNH India

Certican

Active Ingredient:
Everolimus
Origin:
EU

Certican (Everolimus)

Certican (Everolimus) is an oral medication used to prevent organ rejection after transplants. This immunosuppressant helps the body accept transplanted organs by reducing immune system activity.

Manufacturer / TM Owner

Sia Novartis Baltics

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Certican is primarily used to prevent rejection of transplanted organs, such as kidneys, liver, or heart. It works by suppressing the immune system's response to the new organ. Everolimus is often prescribed in combination with other immunosuppressants to enhance effectiveness. Patients may wonder, 'What is Certican used for?' beyond organ transplant scenarios, but its main application remains in transplant medicine.

Side Effects

  • Common effects of Certican may include swelling, headaches, and increased risk of infections due to its immunosuppressant properties. Some users might experience gastrointestinal issues like nausea or diarrhea. These effects vary among individuals and are not exhaustive.

Precautions & Warnings

  • Certican should be handled with care, especially regarding dosage and administration. It is crucial to follow medical guidance to avoid complications. Patients should monitor for signs of infection or unusual bleeding, as the medication can affect the body's ability to fight off illnesses.

Avoid Interactions

  • Certican may interact with other medications, particularly those metabolized by the liver's cytochrome P450 system. Alcohol and certain antifungal or antibiotic drugs can affect its efficacy. Always consult a healthcare provider before combining Certican with other treatments.

Frequently Asked Questions

Certican is primarily used to prevent organ rejection in transplant patients by suppressing the immune system.

Certican is taken orally, typically once daily, but the exact dosage and schedule should be determined by a healthcare provider.

Common side effects may include swelling, headaches, and an increased risk of infections due to its immunosuppressant properties.

Certican may interact with other medications, especially those metabolized by the liver, so it's important to consult a healthcare provider before combining treatments.

Long-term use of Certican should be monitored by a healthcare provider to manage potential side effects and interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Everolimus

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT